Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

BACKGROUND: Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers. METHODS: Expression levels of CD133 and α-DG were assessed by immunohistochemistry in a series of colon cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Coco, Claudio, Zannoni, Gian Franco, Caredda, Emanuele, Sioletic, Stefano, Boninsegna, Alma, Migaldi, Mario, Rizzo, Gianluca, Bonetti, Luca Reggiani, Genovese, Giannicola, Stigliano, Egidio, Cittadini, Achille, Sgambato, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541988/
https://www.ncbi.nlm.nih.gov/pubmed/22964035
http://dx.doi.org/10.1186/1756-9966-31-71

Ejemplares similares

Ejemplares similares